Saingga, Genevie .

HRN: 26-96-96  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2025
CEFUROXIME 500MG (TAB)
05/17/2025
05/24/2025
ORAL
500 Mg/tab
BID
S/p Nsd With Rmle
Waiting Final Action 
05/18/2025
CEFUROXIME 1.5GM (VIAL)
05/18/2025
05/19/2025
IV
1.5gms
Q8hrs
S/P VBAC; 2nd Degree Perineal Laceration
Waiting Final Action 
05/22/2025
CEFUROXIME 500MG (TAB)
05/22/2025
05/25/2025
PO
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: